Maya Balakrishnan

4.3k total citations · 3 hit papers
60 papers, 1.8k citations indexed

About

Maya Balakrishnan is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Maya Balakrishnan has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 24 papers in Hepatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Maya Balakrishnan's work include Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (16 papers) and Liver Diseases and Immunity (7 papers). Maya Balakrishnan is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (16 papers) and Liver Diseases and Immunity (7 papers). Maya Balakrishnan collaborates with scholars based in United States, India and Chile. Maya Balakrishnan's co-authors include David Y. Graham, Aaron P. Thrift, Ashish Sharma, Rollin George, Hashem B. El‐Serag, Fasiha Kanwal, Victor I. Machicao, Michael B. Fallon, Natalia I. Heredia and Xiaotao Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Maya Balakrishnan

54 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Epidemiology of Chronic Liver Disease

2021 352 citations Maya Balakrishnan et al. profile →
Changing Trends in Stomach Cancer Throughout the World

2017 277 citations Maya Balakrishnan, Rollin George et al. Current Gastroenterology Reports profile →
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis

2020 229 citations Maya Balakrishnan, Rubén Hernáez et al. Clinical Gastroenterology and Hepatology profile →

Peers

Countries citing papers authored by Maya Balakrishnan

Since Specialization

Citations

This map shows the geographic impact of Maya Balakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Balakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Balakrishnan more than expected).

Fields of papers citing papers by Maya Balakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Balakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Balakrishnan. The network helps show where Maya Balakrishnan may publish in the future.

Co-authorship network of co-authors of Maya Balakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Balakrishnan. A scholar is included among the top collaborators of Maya Balakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Balakrishnan. Maya Balakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corticosteroids in severe alcohol-associated hepatitis. Not so fast: A systematic review of randomized controlled trials 2025 ·Hepatology ·Michael Shi, (unknown), (unknown), Maya Balakrishnan, (unknown), (unknown), Kavish R. Patidar, Avegail Flores, Vijay H. Shah, Ramón Bataller, Sumeet K. Asrani, Juan Pablo Arab, Fasiha Kanwal, Rubén Hernáez	1
2	Implementation of 5G Cloud Based Technique Development using Radio Access type of Networks 2024 ·(unknown), Maya Balakrishnan, (unknown), (unknown), Anuj Sharma, (unknown)	0
3	An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients 2024 ·Digestive Diseases and Sciences ·Aaron P. Thrift, (unknown), Kyler M. Godwin, Maya Balakrishnan, Hao T. Duong, Rohit Loomba, Fasiha Kanwal, Hashem B. El‐Serag	3
4	A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients 2023 ·The American Journal of Gastroenterology ·Xiaotao Zhang, Carrie R. Daniel, (unknown), (unknown), Shilpa Jain, Fasiha Kanwal, Aaron P. Thrift, Maya Balakrishnan	6
5	The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting 2022 ·Clinical Gastroenterology and Hepatology ·Aaron P. Thrift, Theresa Nguyen, (unknown), Maya Balakrishnan, Fasiha Kanwal, Rohit Loomba, Hao T. Duong, (unknown), Hashem B. El‐Serag	13
6	Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease 2022 ·Journal of Hepatology ·George Cholankeril, Jennifer R. Kramer, Jinna Chu, Xian Yu, Maya Balakrishnan, Liang Li, Hashem B. El‐Serag, Fasiha Kanwal	60
7	Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective 2021 ·Journal of clinical lipidology ·Eugenia Gianos, Dean G. Karalis, (unknown), Rodis Paparodis, (unknown), Maya Balakrishnan, Merle Myerson, Eliot A. Brinton, Robert A. Wild	8
8	MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis 2020 ·Digestive Diseases and Sciences ·Zachary Fricker, (unknown), (unknown), Naga Chalasani, Bashar M. Attar, Maya Balakrishnan, Marwan Ghabril, Michelle T. Long	2
9	Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals 2019 ·PLoS ONE ·(unknown), (unknown), Zachary Fricker, Moinuddin Syed, Eric S. Orman, Lauren Nephew, Eduardo Vilar‐Gómez, James E. Slaven, Naga Chalasani, Maya Balakrishnan, Michelle T. Long, Bashar M. Attar, Marwan Ghabril	20
10	Treatment of Dyslipidemia in Common Liver Diseases 2018 ·Clinical Gastroenterology and Hepatology ·Elizabeth K. Speliotes, Maya Balakrishnan, Lawrence S. Friedman, Kathleen E. Corey	34
11	Alcohol and the Law 2018 ·Clinics in Liver Disease ·Maya Balakrishnan, S. Chris Pappas	3
12	Eliminating Undesirable Variation in Neonatal Practice 2017 ·Clinics in Perinatology ·Maya Balakrishnan, (unknown), Gautham Suresh	19
13	Promoting teamwork may improve infant care processes during delivery room management: Florida perinatal quality collaborative’s approach 2017 ·Journal of Perinatology ·Maya Balakrishnan, (unknown), Linda A. Detman, Branko Miladinović, William M. Sappenfield, John S. Curran, Terri Ashmeade	14
14	Changing Trends in Stomach Cancer Throughout the World breakdown → 2017 ·Current Gastroenterology Reports ·Maya Balakrishnan, Rollin George, Ashish Sharma, David Y. Graham	277
15	Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures 2017 ·Clinical Gastroenterology and Hepatology ·Maya Balakrishnan, Hashem B. El‐Serag, Theresa Nguyen Wenker, (unknown), Fasiha Kanwal, Aaron P. Thrift	9
16	Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey 2016 ·Digestive Diseases and Sciences ·Maya Balakrishnan, Hashem B. El‐Serag, Fasiha Kanwal, Aaron P. Thrift	32
17	Hepatic Arteriolosclerosis 2015 ·The American Journal of Surgical Pathology ·Maya Balakrishnan, Guadalupe García–Tsao, (unknown), Maria Ciarleglio, Dhanpat Jain	14
18	Safety, Acceptability, and Feasibility of Auricular Acupuncture in Neonatal Abstinence Syndrome: A Pilot Study 2015 ·Medical Acupuncture ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Branko Miladinović, Maya Balakrishnan	14
19	Blood urea nitrogen and serum bicarbonate in extremely low birth weight infants receiving higher protein intake in the first week after birth 2011 ·Journal of Perinatology ·Maya Balakrishnan, Richard Tucker, Bonnie E. Stephens, Joseph M. Bliss	18
20	Changing trends in etiology of bacteremia in patients with cancer 2006 ·European Journal of Clinical Microbiology & Infectious Diseases ·A. Safdar, Gabriel Rodriguez, Maya Balakrishnan, Jeffrey J. Tarrand, K. V. I. Rolston	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact